Scientists created a new compound showing promise in treating multiple human cancers.  Watch the video…

A new compound, discovered jointly by international pharmaceutical company Servier, headquartered in France, and Vernalis (R&D), a company based in the UK, has been shown by researchers at the Walter and Eliza Hall Institute and Servier to block a protein that is essential for the sustained growth of up to a quarter of all cancers.

Associate Professor Guillaume Lessene, Walter and Eliza Hall Institute and Associate Professor Andrew Wei, The Alfred Hospital, explain the research.